Sempa JB

Potential for high dynamic range Sedia Limiting Antigen antibody assay to support viral load monitoring during antiretroviral therapy
Sempa JB, Welte A

PLoS ONE

(2024)

https://doi.org/10.1371/journal.pone.0303393
Quantitative interpretation of Sedia LAg Assay test results after HIV diagnosis
Sempa JB, Grebe PE, Welte A

PLOS ONE

(2022)

https://doi.org/10.1371/journal.pone.0271763
A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19
Makoah NA, Tipih T, Litabe MM, Brink M, Sempa JB, Goedhals D, Burt FJ

Future Virology

(2022)

https://doi.org/10.2217/fvl-2021-0211
Cumulative viral load as a predictor of CD4+ T-cell response to antiretroviral therapy using Bayesian statistical models
Sempa JB, Rossouw TM, Lesaffre E, Nieuwoudt M

PLoS One

(2019)

https://doi.org/10.1371/journal.pone.0224723
Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance
Sempa JB, Welte A, Busch MP, Hall J, Hampton D, Facente SN, Keating SM, Marson K, Parkin N, Pilcher CD, Murphy G, Grebe PE

PLoS One

(2019)

https://doi.org/10.1371/journal.pone.0220345
Systematic review of statistically-derived models of immunological response in HIV infected adults on antiretroviral therapy in Sub-Saharan Africa
Sempa JB, Ujeneza EL, Nieuwoudt M

PLoS One

(2017)

https://doi.org/10.1371/journal.pone.0171658
Reevaluating cumulative HIV-1 viral load as a prognostic predictor: predicting opportunistic infection incidence and mortality in a Ugandan cohort
Sempa JB, Dushoff J, Daniels MJ, Castelnuovo B, Kiragga AN, Nieuwoudt M, Bellan SE

American Journal of Epidemiology

(2016)

https://doi.org/10.1093/aje/kwv303